GenSight Biologics S.A. (LON:0RIM)
London
· Delayed Price · Currency is GBP · Price in EUR 0.1800
-0.0186 (-9.37%)
At close: May 23, 2025
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of 28.37 million as of May 27, 2025. Its market cap has decreased by -19.56% in one year.
Market Cap
28.37M
Enterprise Value
42.34M
Revenue
2.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 212.26M to 28.37M, a decrease of -86.63%. That is a compound annual growth rate of -20.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.82B |
| HSBC Holdings | 151.68B |
| Shell | 143.98B |
| Unilever | 117.03B |
| Rio Tinto Group | 78.02B |
| RELX PLC | 75.55B |
| British American Tobacco p.l.c. | 73.07B |
| Rolls-Royce Holdings | 69.88B |